Form 8-K - Current report:
SEC Accession No. 0001193125-20-308422
Filing Date
2020-12-02
Accepted
2020-12-02 16:33:02
Documents
14
Period of Report
2020-12-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d23700d8k.htm   iXBRL 8-K 24899
2 EX-99.1 d23700dex991.htm EX-99.1 8257
6 GRAPHIC g23700dsp5.jpg GRAPHIC 4007
  Complete submission text file 0001193125-20-308422.txt   164649

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20201202.xsd EX-101.SCH 3102
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20201202_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20201202_pre.xml EX-101.PRE 11429
7 EXTRACTED XBRL INSTANCE DOCUMENT d23700d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 201364182
SIC: 2834 Pharmaceutical Preparations